Roswell Park Comprehensive Cancer Center immunology researchers have uncovered a biomarker that may help explain why some patients respond better than others to a common chemotherapy treatment for liver cancer. They hope that their analysis of immune responses among patients receiving sorafenib can lead to more individualized treatment options and better overall outcomes for patients diagnosed with the disease.

A group of retired firefighters dedicated to raising funds for cancer research recently visited Roswell Park Comprehensive Cancer Center to make a significant donation that will go toward brain cancer research.

Researchers from Roswell Park Comprehensive Cancer Center have developed a new bioinformatics-based approach for monitoring key changes in cancer cells. They describe their work to develop this data-driven method and how it can be used to enhance and personalize cancer treatment in a recent article in the journal Nature Communications.

A record of outstanding clinical care and services has once again earned Roswell Park Comprehensive Cancer Center recognition as one of the top cancer hospitals in the country. The Buffalo-based cancer center has been named to U.S. News & World Report’s annual list of the Best Hospitals in the nation, and number 14 on its list of Best Hospitals for Cancer. U.S. News’ data-driven ranking places Roswell Park among the top 1.5% of cancer hospitals, and as a high-performing center in two subspecialty areas: colon cancer surgery and lung cancer surgery.

One of Roswell Park Comprehensive Cancer Center’s most distinguished researchers has been recognized again for his contributions to advance the fight against ovarian cancer. Ovarian Cancer Research Alliance (OCRA) awarded its Rosalind Franklin Prize for Excellence in Ovarian Cancer Research to Roswell Park Deputy Director Kunle Odunsi, MD, PhD, FRCOG, FACOG, earlier this month during the organization’s 2019 Ovarian Cancer National Conference in Seattle, Washington.

Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announced a $100,000 Hyundai Impact Award Grant to Roswell Park Comprehensive Cancer Center to continue its long-standing fight against pediatric cancer. The center is one of 77 recipients receiving a combined $16 million in new grants this year to develop innovative approaches to finding a cure for the disease. The Hyundai Impact Award was presented to Matthew Barth, MD at Roswell Park Wednesday.